VRDN Viridian Therapeutics19.08+0.60 (+3.3%)
VRDN Viridian Therapeutics18.46+0.56 (+3.1%)
After Hours Gainer
VRDN Viridian Therapeutics17.90+0.51+2.9%
After Hours:19.81+1.91 (+10.7%)
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
Business WireFri, 26-Jun 6:00 PM
After Hours:19.45+1.55 (+8.7%)
VRDN Viridian Therapeutics17.27-0.26 (-1.5%)